H-YMLDL^QPET-OH

Ref. 3D-PP47913

Información del producto

• Nombre: H-YMLDL^QPET-OH

Descripción

Peptide H-YMLDL^QPET-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-YMLDL^QPET-OH include the following: Screening and Identification of Predicted Epitopes of HLA-A2-restricted Cytotoxic T Lymphocytes Derived from the HPV16 E7 Antigen Y XU, F Hao, Z Song, B Zhong - Chinese Journal of , 1994 - pesquisa.bvsalud.orghttps://pesquisa.bvsalud.org/portal/resource/pt/wpr-522523 Novel Canonical and Non-Canonical Antigens That Extend Current Targets for Immunotherapy of HPV-Driven Cervical Cancer X Peng, I Woodhouse , G Hancock, R Parker - Available at SSRN - papers.ssrn.comhttps://papers.ssrn.com/sol3/papers.cfm?abstract_id=4022700 Novel canonical and non-canonical viral antigens extend current targets for immunotherapy of HPV-driven cervical cancer X Peng, I Woodhouse , G Hancock, R Parker, K Marx - Iscience, 2023 - cell.comhttps://www.cell.com/iscience/pdf/S2589-0042(23)00178-5.pdf Large libraries of single-chain trimer peptide-MHCs enable antigen-specific CD8+ T cell discovery and analysis W Chour , J Choi , J Xie , ME Chaffee, TM Schmitt - Communications , 2023 - nature.comhttps://www.nature.com/articles/s42003-023-04899-8 A TCR mimic monoclonal antibody for the HPV-16 E7-epitope p11-19/HLA-A* 02: 01 complex T Dao, S Mun, T Korontsvit, AG Khan, MA Pohl, T White - Plos one, 2022 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0265534 Development of mass spectrometry methodology for direct identification of viral epitopes from MHC I molecules R Blatnik - 2017 - archiv.ub.uni-heidelberg.dehttps://archiv.ub.uni-heidelberg.de/volltextserver/19834/ Decreased levels of alternative co-stimulatory receptors OX40 and 4-1BB characterise T cells from head and neck cancer patients P Baruah, M Lee , T Odutoye, P Williamson, N Hyde - Immunobiology, 2012 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0171298511002531 Immunological evaluation of a novel HLA-A2 restricted phosphopeptide of tumor associated Antigen, TRAP1, on cancer therapy MH Lin, KY Shen, BS Liu, IH Chen, YP Sher , GC Tseng - Vaccine: X, 2019 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S259013621930018X TCR-mimic bispecific antibodies targeting LMP2A show potent activity against EBV malignancies M Ahmed, A Lopez-Albaitero, D Pankov, BH Santich - JCI insight, 2018 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5916246/ ARTEMIS: a novel mass-spec platform for HLA-restricted self and disease-associated peptide discovery KAK Finton, MY Brusniak, LA Jones, C Lin - Frontiers in , 2021 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fimmu.2021.658372/full Human Papillomavirus Type 16 E7 Peptide-Directed CD8+ T Cells from Patients with Cervical Cancer Are Cross-Reactive with the Coronavirus NS2 Protein K Nilges, H Höhn, H Pilch, C Neukirch - Journal of , 2003 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.77.9.5464-5474.2003 Katja Nilges, Hanni Höhn, Henryk Pilch, Claudia Neukirch K Freitag, PJ Talbot , MJ Maeurer - Citeseerhttps://citeseerx.ist.psu.edu/document?repid=rep1&type=pdf&doi=42484c04bb79d75c8ec3ae0ecfa79514359c66da Large libraries of single-chain trimer peptide-MHCs enable rapid antigen-specific CD8+ T cell discovery and analysis J Heath , W Chour , J Choi , J Xie , M Chaffee - Research , 2022 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681053/ New tetramer technology offers new aspects in the definition of appropriate HPV target epitopes for novel vaccine designs in cervical cancer patients H Pilch, M Schmidt , E Steiner, R Seufert - Geburtshilfe und , 2005 - thieme-connect.comhttps://www.thieme-connect.com/products/ejournals/html/10.1055/s-2005-837534 CD8+ CD45RA+ CD27-CD28-T-cell subset in PBL of cervical cancer patients representing CD8+ T-cells being able to recognize cervical cancer associated antigens H Pilch, H Hoehn, M Schmidt , E Steiner - Zentralblatt fur , 2002 - thieme-connect.comhttps://www.thieme-connect.com/products/ejournals/html/10.1055/s-2002-38130 Definition of the HLA-A2 restricted peptides recognized by human CD8+ effector T cells by flow-assisted sorting of the CD8+ CD45RA+ CD28- T cell H Höhn, M Julch, H Pilch, C Kortsik - Clinical & , 2003 - academic.oup.comhttps://academic.oup.com/cei/article-abstract/131/1/102/6458801 LSD1 inhibition enhances the immunogenicity of mesenchymal stromal cells by eliciting a dsRNA stress response F Mardani, W Saad, N El-Hachem , JP Bikorimana - Cells, 2022 - mdpi.comhttps://www.mdpi.com/2073-4409/11/11/1816 Direct identification of an HPV-16 tumor antigen from cervical cancer biopsy specimens DB Keskin , B Reinhold , SY Lee, G Zhang - Frontiers in , 2011 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fimmu.2011.00075/full Engineered T cells targeting E7 mediate regression of human papillomavirus cancers in a murine model BY Jin, TE Campbell, LM Draper , S Stevanovic - JCI insight, 2018 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5931134/ Why must T cells be cross-reactive? AK Sewell - Nature Reviews Immunology, 2012 - nature.comhttps://www.nature.com/articles/nri3279

• Marca: Biosynth